INCY vs WGSWW · P/E 14, rev $5.14B vs rev $305.4M
Incyte Corporation (INCY) versus GeneDx Holdings Corp. (WGSWW) — a side-by-side from cached financials, not a winner call.
Incyte Corporation (INCY) is a biotechnology company listed on US.
GeneDx Holdings Corp. (WGSWW) common stock listed on NASDAQ.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Latest reported WGSWW revenue for 2024-12-31 was $305.4M. Net income was -$52.3M. Revenue was up 50.8% from 2023-12-31 to 2024-12-31.
INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Not investment advice. Open the INCY and WGSWW stock pages for the full models.
Not investment advice.